Pierre Luzeau has been President & CEO of Seqens (formerly known as Novacap) since 2007. He has over 25 years experience in the industry with ISA-Riber, Thomson CSF, Pechiney and Rhodia. He is also the Chairman of the Competitiveness Committee of UIC (Trade Professional of Chemical Industries) and member of the Strategic Committee of the French Chemical Industry. He holds a Magister in Chemistry from ENS (Ecole Normale Supérieure) and a PhD in solid-state physics and MBA at CDI.
“The reputation of Institut Mérieux around the world, its values, the professionalism of the investment team at Mérieux Equity Partners and the quality of its network are all advantages that Seqens benefits from.”